Blue Jet Healthcare Limited (BLUEJET) — Board Meeting Announcement
Blue Jet Healthcare Limited announced an Extraordinary General Meeting on June 17, 2026, to seek shareholder approval for raising up to ₹10,000 million through a Qualified Institutional Placement (QIP) or other instruments, including convertible securities, with a maximum 5% discount. The resolution empowers the Board to determine pricing, allotment terms, and investor eligibility, restricting allocations to qualified institutional buyers and excluding promoters. Proceeds will be used for business growth, working capital, and capital expenditures, with temporary investments in approved instruments until deployment. The filing emphasizes compliance with SEBI ICDR, Companies Act, and other regulations, and includes detailed e-voting procedures for remote participation.
📄 View Original Announcement (PDF)
About Blue Jet Healthcare Limited (BLUEJET)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.